Arkadios Wealth Advisors’s Amphastar Pharmaceuticals AMPH Stock Holding History

Arkadios Wealth Advisors’s Portfolio AMPH Stock Details AMPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-26,303	Closed	-$704K	–	1699
2025 Q4	$704K	Sell	26,303 -9,705	-27%	-$250K	0.01%	858
2025 Q3	$960K	Buy	36,008 +845	+2%	+$21.8K	0.02%	657
2025 Q2	$807K	Buy	35,163 +1,197	+4%	+$29.7K	0.02%	651
2025 Q1	$985K	Buy	33,966 +6,002	+21%	+$192K	0.04%	464
2024 Q4	$1.04M	Buy	27,964 +1,379	+5%	+$63.1K	0.06%	325
2024 Q3	$1.29M	Buy	26,585 +830	+3%	+$36.4K	0.07%	265
2024 Q2	$1.03M	Buy	+25,755	New	+$1.07M	0.07%	276

Other funds holding AMPH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return

Arkadios Wealth Advisors's AMPH Position: Q1 2026 in Review

Arkadios Wealth Advisors sold out of Amphastar Pharmaceuticals (AMPH) in Q1 2026, closing a stake of 26,303 shares — an estimated $704K sold.

Arkadios Wealth Advisors first reported a position in AMPH in Q2 2024 and held it in 7 quarters. The position peaked at $1.29M in Q3 2024. 215 funds tracked by Wall St. Rank hold AMPH as of Q1 2026.

Arkadios Wealth Advisors reported no remaining Amphastar Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
Arkadios Wealth Advisors sold 26,303 Amphastar Pharmaceuticals shares in Q1 2026, an estimated $704K.
Arkadios Wealth Advisors first reported a position in Amphastar Pharmaceuticals in Q2 2024 and held it in 7 quarters.
Arkadios Wealth Advisors's Amphastar Pharmaceuticals position peaked at $1.29M in Q3 2024.
215 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2026.

Based on Arkadios Wealth Advisors's 13F filing for Q1 2026, filed 18 May 2026.